[
  {
    "ts": "2026-02-03T01:53:38+00:00",
    "headline": "ResMed Inc. (RMD): A Bull Case Theory",
    "summary": "We came across a bullish thesis on ResMed Inc. on Best Anchor Stocks’s Substack. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.’s share was trading at $257.61 as of January 29th. RMD’s trailing and forward P/E were 26.38 and 23.70 respectively according to Yahoo Finance. ResMed Inc. develops, manufactures, distributes, and markets […]",
    "url": "https://finance.yahoo.com/news/resmed-inc-rmd-bull-case-015338259.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ba8f2f93-0320-3436-af41-eaa5544f9aa2",
      "content": {
        "id": "ba8f2f93-0320-3436-af41-eaa5544f9aa2",
        "contentType": "STORY",
        "title": "ResMed Inc. (RMD): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on ResMed Inc. on Best Anchor Stocks’s Substack. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.’s share was trading at $257.61 as of January 29th. RMD’s trailing and forward P/E were 26.38 and 23.70 respectively according to Yahoo Finance. ResMed Inc. develops, manufactures, distributes, and markets […]",
        "pubDate": "2026-02-03T01:53:38Z",
        "displayTime": "2026-02-03T01:53:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/88a26fec070ee9681fc54d0ff698d832",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Veeva Expands Basics Suite as Over 100 Biotechs Adopt Platform for Scalable Growth",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cX3lEeTrGA28LvvO3s8euw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/88a26fec070ee9681fc54d0ff698d832.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/v1iMY_uAAXP743MjQb1ELw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/88a26fec070ee9681fc54d0ff698d832.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/resmed-inc-rmd-bull-case-015338259.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/resmed-inc-rmd-bull-case-015338259.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RMD"
            },
            {
              "symbol": "RSMDF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]